Your browser doesn't support javascript.
COVID-19 and Antimicrobial Resistance: Data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance-WHONET-Greece (January 2018-March 2021).
Polemis, Michalis; Mandilara, Georgia; Pappa, Olga; Argyropoulou, Athina; Perivolioti, Efstathia; Koudoumnakis, Nikolaos; Pournaras, Spyros; Vasilakopoulou, Alexandra; Vourli, Sophia; Katsifa, Helen; Karampatakis, Theodoros; Papavasiliou, Anastasia; Petinaki, Efthymia; Xitsas, Stylianos; Skoura, Lemonia; Protonotariou, Efthymia; Mantzana, Paraskevi; Gartzonika, Konstantina; Priavali, Efthalia; Kallinteri, Amalia; Giannopoulou, Panagiota; Charalampaki, Nikoletta; Memezas, Meletis; Calina Oana, Zervaki; Papadogianni, Marina; Panopoulou, Maria; Koutsidou, Athanasia; Vatopoulos, Alkiviadis; Tryfinopoulou, Kyriaki.
  • Polemis M; Central Public Health Laboratory, National Public Health Organization, 16672 Vari, Greece.
  • Mandilara G; School of Public Health, University of West Attica, 11521 Athens, Greece.
  • Pappa O; Central Public Health Laboratory, National Public Health Organization, 16672 Vari, Greece.
  • Argyropoulou A; "Evaggelismos" General Hospital, 10676 Athens, Greece.
  • Perivolioti E; "Evaggelismos" General Hospital, 10676 Athens, Greece.
  • Koudoumnakis N; "Evaggelismos" General Hospital, 10676 Athens, Greece.
  • Pournaras S; "Attikon" University Hospital, 12462 Athens, Greece.
  • Vasilakopoulou A; "Attikon" University Hospital, 12462 Athens, Greece.
  • Vourli S; "Attikon" University Hospital, 12462 Athens, Greece.
  • Katsifa H; General Hospital "George Papanikolaou", 57010 Thessaloniki, Greece.
  • Karampatakis T; General Hospital "George Papanikolaou", 57010 Thessaloniki, Greece.
  • Papavasiliou A; General Hospital "George Papanikolaou", 57010 Thessaloniki, Greece.
  • Petinaki E; University Hospital of Larissa, 41110 Larissa, Greece.
  • Xitsas S; University Hospital of Larissa, 41110 Larissa, Greece.
  • Skoura L; "Axepa" University Hospital, 54636 Thessaloniki, Greece.
  • Protonotariou E; "Axepa" University Hospital, 54636 Thessaloniki, Greece.
  • Mantzana P; "Axepa" University Hospital, 54636 Thessaloniki, Greece.
  • Gartzonika K; University Hospital of Ioannina, 45500 Ioannina, Greece.
  • Priavali E; University Hospital of Ioannina, 45500 Ioannina, Greece.
  • Kallinteri A; University Hospital of Ioannina, 45500 Ioannina, Greece.
  • Giannopoulou P; "Thriasio" General Hospital of Elefsina, 19600 Athens, Greece.
  • Charalampaki N; "Thriasio" General Hospital of Elefsina, 19600 Athens, Greece.
  • Memezas M; "Thriasio" General Hospital of Elefsina, 19600 Athens, Greece.
  • Calina Oana Z; "St. George" General Hospital, 73300 Crete (Chania), Greece.
  • Papadogianni M; "St. George" General Hospital, 73300 Crete (Chania), Greece.
  • Panopoulou M; University Hospital of Alexandroupolis, 68100 Alexandroupoli, Greece.
  • Koutsidou A; University Hospital of Alexandroupolis, 68100 Alexandroupoli, Greece.
  • Vatopoulos A; School of Public Health, University of West Attica, 11521 Athens, Greece.
  • Tryfinopoulou K; Central Public Health Laboratory, National Public Health Organization, 16672 Vari, Greece.
Life (Basel) ; 11(10)2021 Sep 22.
Article in English | MEDLINE | ID: covidwho-1438655
ABSTRACT
Changes in hospitals' daily practice due to COVID-19 pandemic may have an impact on antimicrobial resistance (AMR). We aimed to assess this possible impact as captured by the Greek Electronic System for the Surveillance of Antimicrobial Resistance (WHONET-Greece). Routine susceptibility data of 17,837 Gram-negative and Gram-positive bacterial isolates from blood and respiratory specimens of hospitalized patients in nine COVID-19 tertiary hospitals were used in order to identify potential differences in AMR trends in the last three years, divided into two periods, January 2018-March 2020 and April 2020-March 2021. Interrupted time-series analysis was used to evaluate differences in the trends of non-susceptibility before and after the changes due to COVID-19. We found significant differences in the slope of non-susceptibility trends of Acinetobacter baumannii blood and respiratory isolates to amikacin, tigecycline and colistin; of Klebsiella pneumoniae blood and respiratory isolates to meropenem and tigecycline; and of Pseudomonas aeruginosa respiratory isolates to imipenem, meropenem and levofloxacin. Additionally, we found significant differences in the slope of non-susceptibility trends of Staphylococcus aureus isolates to oxacillin and of Enterococcus faecium isolates to glycopeptides. Assessing in this early stage, through surveillance of routine laboratory data, the way a new global threat like COVID-19 could affect an already ongoing pandemic like AMR provides useful information for prompt action.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Language: English Year: 2021 Document Type: Article Affiliation country: Life11100996

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Language: English Year: 2021 Document Type: Article Affiliation country: Life11100996